Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung

计划入组 315 人 · 首次发布于 2016 年 8 月 2 日

Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism

计划入组 200 人 · 首次发布于 2019 年 10 月 11 日

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

计划入组 2,932 人 · 首次发布于 2024 年 9 月 24 日

Warfarin(Coumadin, Jantoven)

C₁₉H₁₆O₄ · Rx

Betrixaban(BEVYXXA)

C₂₃H₂₂ClN₅O₃

Streptokinase

Rx

Cadrenal Therapeutics

United States

Angiotensin II and Thromboembolism Risk Re-evaluated in Critical Care

Apixaban Shows Superior Safety Profile Over Rivaroxaban in Major Venous Thromboembolism Trial

Imperative Care Launches CLEAR-IT Study to Establish Clinical Standards for Peripheral Thromboembolism Treatment